SE7701441L - Nytt piperazinyluracilsalt - Google Patents

Nytt piperazinyluracilsalt

Info

Publication number
SE7701441L
SE7701441L SE7701441A SE7701441A SE7701441L SE 7701441 L SE7701441 L SE 7701441L SE 7701441 A SE7701441 A SE 7701441A SE 7701441 A SE7701441 A SE 7701441A SE 7701441 L SE7701441 L SE 7701441L
Authority
SE
Sweden
Prior art keywords
urapidil
furosemide
combination
salt
piperazinyluracil
Prior art date
Application number
SE7701441A
Other languages
English (en)
Swedish (sv)
Inventor
H Amschler
K Klemm
G Ludwig
W Schoetensack
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of SE7701441L publication Critical patent/SE7701441L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7701441A 1976-02-09 1977-02-09 Nytt piperazinyluracilsalt SE7701441L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU74319A LU74319A1 (el) 1976-02-09 1976-02-09

Publications (1)

Publication Number Publication Date
SE7701441L true SE7701441L (sv) 1977-08-10

Family

ID=19728151

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701441A SE7701441L (sv) 1976-02-09 1977-02-09 Nytt piperazinyluracilsalt

Country Status (20)

Country Link
US (1) US4131678A (el)
JP (2) JPS5296718A (el)
AT (1) AT347478B (el)
BE (1) BE851267A (el)
CA (1) CA1065865A (el)
CH (1) CH625792A5 (el)
DE (1) DE2704935C2 (el)
DK (1) DK52877A (el)
ES (1) ES455721A1 (el)
FI (1) FI61891C (el)
FR (1) FR2340316A1 (el)
GB (1) GB1512771A (el)
IE (1) IE44461B1 (el)
IL (1) IL51400A (el)
IT (1) IT1075919B (el)
LU (1) LU74319A1 (el)
NL (1) NL7701289A (el)
NO (1) NO145440C (el)
SE (1) SE7701441L (el)
YU (1) YU32477A (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58130183U (ja) * 1982-02-26 1983-09-02 株式会社ブレスト工業研究所 空調ダクト等の吊持装置
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
CN100353944C (zh) * 2004-06-24 2007-12-12 杨立新 乌拉地尔大容量注射液、其制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
BE755015A (fr) * 1969-08-20 1971-02-01 Byk Gulden Lomberg Chem Fab Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation
JPS5212560A (en) * 1975-07-21 1977-01-31 Hitachi Ltd Electronic beam probe control device

Also Published As

Publication number Publication date
FR2340316A1 (fr) 1977-09-02
CH625792A5 (el) 1981-10-15
BE851267A (fr) 1977-08-09
FR2340316B1 (el) 1980-02-08
DE2704935A1 (de) 1977-08-11
IE44461L (en) 1977-08-09
FI61891C (fi) 1982-10-11
JPS5726618A (en) 1982-02-12
IL51400A (en) 1980-12-31
JPS5296718A (en) 1977-08-13
GB1512771A (en) 1978-06-01
FI61891B (fi) 1982-06-30
LU74319A1 (el) 1977-08-19
US4131678A (en) 1978-12-26
CA1065865A (en) 1979-11-06
ES455721A1 (es) 1978-01-01
AT347478B (de) 1978-12-27
NL7701289A (nl) 1977-08-11
IT1075919B (it) 1985-04-22
YU32477A (en) 1982-06-30
JPS5713544B2 (el) 1982-03-17
DE2704935C2 (de) 1985-01-10
NO145440C (no) 1982-03-24
IE44461B1 (en) 1981-12-02
NO145440B (no) 1981-12-14
NO770411L (no) 1977-08-10
FI770406A (el) 1977-08-10
IL51400A0 (en) 1977-04-29
ATA81777A (de) 1978-05-15
DK52877A (da) 1977-08-10

Similar Documents

Publication Publication Date Title
ES2106794T3 (es) Utilizacion del inositol-trifosfato para el tratamiento de inflamaciones.
SE437837B (sv) Polypeptid for att kontrollera och/eller forbettra reproduktionen hos djur jemte veteriner komposition innehallande nemnda polypeptid som aktiv bestandsdel
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
ES2105333T3 (es) Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
DK0574457T3 (da) Antiviral nucleosidkombination
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
ES2061307T3 (es) Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
SE7502341L (el)
KR890015742A (ko) 이병치료용 국소 제제
SE7701441L (sv) Nytt piperazinyluracilsalt
DK297976A (da) Rullepumpehoved til skiftende pumpning navnlig egnet til cirkulation af blod uden for legemet
FI860018A (fi) Laekemedelspreparat med reducerad toxisitet.
DK178188A (da) Antivirusmiddel
SE7700626L (sv) Patientstol for ltandbehandling
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
NO902157L (no) Butensyrederivater for terapeutisk anvendelse.
SE7708176L (sv) Bensamidforeningar
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
FR2362852A1 (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
IT7825497A0 (it) Derivati di 1,2,4-ossadiazolo, loro preparazione e loro applicazione in terapia.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ES2054097T3 (es) Agente para el tratamiento de enfermedades inflamatorias cronicas del intestino.
IT1114869B (it) Derivati attivi di metilammina,composizioni terapeutiche che li contengono e procedimenti per preparare i detti derivati e le dette composizioni
SE8802040D0 (sv) New use

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7701441-3